BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 12928790)

  • 1. [Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model?].
    Stein HJ; von Rahden BH; Höfler H; Siewert JR
    Chirurg; 2003 Aug; 74(8):703-8. PubMed ID: 12928790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
    Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
    Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of intestinal metaplasia in the gastric cardia.
    El-Serag HB; Sonnenberg A; Jamal MM; Kunkel D; Crooks L; Feddersen RM
    Am J Gastroenterol; 1999 Mar; 94(3):622-7. PubMed ID: 10086641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma of the lower esophagus and the esophagogastric junction.
    Potet F; Fléjou JF; Gervaz H; Paraf F
    Semin Diagn Pathol; 1991 Aug; 8(3):126-36. PubMed ID: 1925120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification.
    Siewert JR; Feith M; Stein HJ
    J Surg Oncol; 2005 Jun; 90(3):139-46; discussion 146. PubMed ID: 15895452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors.
    Mattioli S; Ruffato A; Di Simone MP; Corti B; D'Errico A; Lugaresi ML; Mattioli B; D'Ovidio F
    Ann Thorac Surg; 2007 May; 83(5):1814-9. PubMed ID: 17462405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carditis, intestinal metaplasia and adenocarcinoma of oesophagogastric junction.
    Conio M; Filiberti R; Blanchi S; Giacosa A
    Eur J Cancer Prev; 2001 Dec; 10(6):483-7. PubMed ID: 11916346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction.
    Marsman WA; Tytgat GN; ten Kate FJ; van Lanschot JJ
    J Surg Oncol; 2005 Dec; 92(3):160-8. PubMed ID: 16299781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
    Asthana N; Mandich D; Ligato S
    Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers.
    Morales CP; Spechler SJ
    Am J Gastroenterol; 2003 Apr; 98(4):759-62. PubMed ID: 12738452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus: histopathologic definitions and diagnostic criteria.
    Mueller J; Werner M; Stolte M
    World J Surg; 2004 Feb; 28(2):148-54. PubMed ID: 14727064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.
    Buskens CJ; Hulscher JB; van Gulik TM; Ten Kate FJ; van Lanschot JJ
    J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology of Barrett's cancer.
    Atherfold PA; Jankowski JA
    Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adenocarcinoma of the esophago-gastric junction arising after endoscopic laser photocoagulation ablation of the short segment of Barrett's esophagus].
    Macey N; Le Dréau G; Volant A; Vaucher C; Nousbaum JB; Gouérou H; Robaszkiewicz M
    Gastroenterol Clin Biol; 2001 Feb; 25(2):204-6. PubMed ID: 11319449
    [No Abstract]   [Full Text] [Related]  

  • 20. Dysplastic gastroesophageal junction nodules--a precursor to junctional adenocarcinoma.
    Gangarosa L; Halter S; Mertz H
    Am J Gastroenterol; 1999 Mar; 94(3):835-8. PubMed ID: 10086675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.